Skip to main content
ICYMI Multiple Sclerosis
FULL MENU
FULL MENU
Presented by
MDedge Neurology
Clinical Topics
Conference Coverage
Literature Review
MD-IQ
Clinical Edge Journal Scan
Audio
Tobias Derfuss, MD, Part 2
Neurology Reviews
. 2013 November;21(11)
Tobias Derfuss, MD, reviews multiple sclerosis drugs in the pipeline.
Recommended Reading
Sodium Intake Is Associated With Increased Disease Activity in MS
ICYMI Multiple Sclerosis
2010 McDonald Criteria Are Effective for Early Diagnosis of Pediatric MS
ICYMI Multiple Sclerosis
Does Birth Month Affect the Risk for MS?
ICYMI Multiple Sclerosis
The First Attack of Multiple Sclerosis May Target Gray Matter
ICYMI Multiple Sclerosis
COMMENTARY—The Principal Site of MS-Related Tissue Injury Remains Unclear
ICYMI Multiple Sclerosis
Pyramidal Dysfunction May Predict Disability Progression in CIS
ICYMI Multiple Sclerosis
Which Walking Tests Are Most Responsive to Improvement in Patients With MS?
ICYMI Multiple Sclerosis
New and Noteworthy Information—November 2013
ICYMI Multiple Sclerosis
Serum Vitamin D Level May Predict Long-Term MS Activity and Severity
ICYMI Multiple Sclerosis
Which Factors Predict Whether a Patient With MS Will Switch Therapies?
ICYMI Multiple Sclerosis
Multiple Sclerosis
FULL MENU
FULL MENU
Presented by
FULL MENU
FULL MENU
Clinical Topics
Conference Coverage
Expert Perspectives
Literature Review
MD-IQ
Clinical Edge Journal Scan
More
MDedge Neurology
Clinical Topics
Conference Coverage
Expert Perspectives
Literature Review
MD-IQ
Clinical Edge Journal Scan
More
MDedge Neurology